Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;48(1):161-168.
doi: 10.1111/jog.15031. Epub 2021 Oct 21.

Effect of modified levonorgestrel-releasing intrauterine system in human adenomyosis with heavy menstrual bleeding

Hong Yang  1 , Shengtan Wang  1 , Xiaoyan Fu  2 , Ruihong Lan  1 , Humin Gong  1
Affiliations

Effect of modified levonorgestrel-releasing intrauterine system in human adenomyosis with heavy menstrual bleeding

Hong Yang et al. J Obstet Gynaecol Res. 2022 Jan.

Abstract

Aim: The levonorgestrel-releasing intrauterine (LNG-IUS) system is an effective primary treatment for adenomyosis; however, it has high expulsion rates. We aimed to modify the system-allowing affixion to the myometrium-and evaluate the expulsion rate, effectiveness, and side effects in patients with adenomyosis and heavy menstrual bleeding.

Methods: This study included patients with adenomyosis and heavy menstrual bleeding who underwent implantation of: a modified LNG-IUS (experimental group, n = 47); and the original system after gonadotropin-releasing hormone agonist treatment (control group, n = 47), between January 2014 and April 2016.

Results: In the experimental group, two device expulsions occurred 12-18 months postimplantation. In the remaining 45 patients, the system was safely removed after the 60-month validity period, and no extrauterine device movement or infection occurred. In the control group, downward displacement and expulsion of the device occurred in eight (17%) patients within 60 months. The 5-year total expulsion rates were 4.3% and 17.0% in the experimental and control groups, respectively (p = 0.045). There were significant changes in the pretreatment severity of dysmenorrhea, menstrual volume, uterine volume (cm3 ), and hemoglobin level in each group compared with after 1 year (p < 0.01 in all groups). The severity of dysmenorrhea, menstrual volume, uterine volume, and hemoglobin level after 1 year were similar between the two groups (p > 0.05 in all groups).

Conclusions: Use of the modified LNG-IUS is a safe, cost-effective, and simple method for reducing the downward movement and expulsion rate in patients with adenomyosis and heavy menstrual bleeding.

Keywords: IUD expulsion; diffuse adenomyosis; heavy menstrual bleeding; hormone-releasing intrauterine devices; levonorgestrel.

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

FIGURE 1
FIGURE 1
Intrauterine devices. (a) Structural diagram of a frameless fixed intrauterine device (GyneFix; Tianjin Medic Medical Equipment Co., Ltd., Tianjin, China). (b) Original levonorgestrel‐releasing intrauterine system. (c) Modified levonorgestrel‐releasing intrauterine system. (d) Schematic diagram of the modified levonorgestrel‐releasing intrauterine system fixed to the basal muscle layer of the uterus
FIGURE 2
FIGURE 2
Schematic diagram of the anchoring knot
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Li L, Leng JH, Jia SZ, et al. Analysis of unplanned taking‐out and expulsion of LNG‐IUS and related factors during the treatment of symptomatic adenomyosis (in Chinese). Chin J Pract Gynecol Obstet. 2016;11:1088–92.
    1. Youm J, Lee HJ, Kim SK, Kim H, Jee BC. Factors affecting the spontaneous expulsion of the levonorgestrel‐releasing intrauterine system. Int J Gynaecol Obstet. 2014;126:165–9. - PubMed
    1. Lockhat FB, Emembolu JO, Konje JC. The evaluation of the effectiveness of an intrauterine‐administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the disease. Hum Reprod. 2004;19:179–84. - PubMed
    1. Park DS, Kim ML, Song T, et al. Clinical experiences of the levonorgestrel‐releasing intrauterine system in patients with large symptomatic adenomyosis. Taiwan J Obstet Gynecol. 2015;54:412–5. - PubMed
    1. Cooperative Group of Endometriosis, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association . Guideline for the diagnosis and treatment of endometriosis. Zhonghua Fu Chan Ke Za Zhi. 2015;50:161–9. (in Chinese). - PubMed